Medical News

RSS

U.S. food prices could rise up to 4%, USDA says

U.S. food prices will "rise as much as 4% this year, more than the 2% to 3% estimated last month, after a surge in prices for farm goods, the U.S. Department of Agriculture" forecast Thursday during the agency's outlook conference in Washington, Bloomberg/Los Angeles Times reports.

28 Feb 2011

Despite FDA action, Deston still believes Auralgan as a safe and effective drug product

Deston Therapeutics LLC announced today that it is currently exploring its options to respond to a recent seizure of its Auralgan Otic Solution by the Federal Government and that it still believes that Auralgan is a safe and effective drug product.

28 Feb 2011

New horse stem cell discovery aids in preclinical model development for human degenerative diseases

In a world first, pluripotent stem cells have been generated from horses by a team of researchers led by Dr. Andras Nagy at the Samuel Lunenfeld Research Institute of Mount Sinai Hospital and Dr. Lawrence Smith at the University of Montreal's Faculty of Veterinary Science.

28 Feb 2011

Researchers discover new mechanism of beta cell destruction not previously known

The death of insulin-producing beta cells in the pancreas is a core defect in diabetes. Scientists in Italy and Texas now have discovered a new way that these cells die - by toxic imbalance of a molecule secreted by other pancreatic cells.

28 Feb 2011

First study to show link between AVPR1A gene variants with listening to music

Music is listened in all known cultures. Similarities between human and animal song have been detected: both contain a message, an intention that reflects innate emotional state that is interpreted correctly even among different species.

28 Feb 2011

Survey: 65% of patients in hospitals experience pain prevalence

Nearly two-thirds of the hospital in-patients who took part in a survey had experienced pain in the last 24 hours and 42% of those rated their pain as more than seven out of ten, where ten was the worst pain imaginable, according to the March issue of the Journal of Clinical Nursing.

28 Feb 2011

Affymetrix introduces new GeneChip miRNA 2.0 Array

Affymetrix, Inc. today launched the GeneChip miRNA 2.0 Array. This enhanced version of its best-in-class microRNA interrogation solution will support the research community's pursuit of personalized medicine by accelerating the identification of biomarkers and gene expression signatures associated with disease.

28 Feb 2011

New study: Free radicals play a key role in heart physiology

Fear of free radicals may be exaggerated, according to scientists from the Swedish medical university Karolinska Institutet. A new study, published in The Journal of Physiology, shows that free radicals act as signal substances that cause the heart to beat with the correct force.

28 Feb 2011

Governors want flexibility from federal officials on health issues

The National Governors Association is meeting in Washington this weekend and some of the state leaders spoke out about their difficulties funding health programs and flexibility and changes they would like to see from the federal government.

28 Feb 2011

Scientific Learning introduces new series of Virtual Brain Seminars for students

In today's economy, traveling to see renowned educators and authors speak at national conferences and seminars is no longer an option for many K-12 educators. Beginning this month, however, educators will have the opportunity to hear from nationally recognized experts in education, technology and neuroscience with the launch of a new series of Virtual Brain Seminars presented by Scientific Learning, makers of the Fast ForWord and Reading Assistant family of products.

28 Feb 2011

New national campaign to help reduce risk of pressure ulcers in hospital and post-acute care settings

ConvaTec, a world-leading developer and marketer of innovative medical technologies for community and hospital care, today announced the introduction of a new national campaign to help reduce the risk of pressure ulcers in hospital and post-acute care settings.

28 Feb 2011

Selcia completes drug discovery project with ExonHit Therapeutics using fragment screening technology

Selcia Ltd today announced the successful completion of a drug discovery project with ExonHit Therapeutics SA, using Selcia's fragment screening technology. Novel and weak affinity hits were identified from Selcia's Fragment Library, using their proprietary CEfrag technique.

28 Feb 2011

Preliminary top-line results from cariprazine 8-week Phase II trial against major depressive disorder

Forest Laboratories, Inc. and Gedeon Richter Plc. today announced preliminary top-line results from an 8-week Phase II clinical trial of the novel, investigational antipsychotic agent cariprazine as adjunctive therapy in major depressive disorder.

28 Feb 2011

Temporary budget compromise would not defund health law

News outlets covered the ongoing saga of whether Congress and the president will avert a government shutdown.

28 Feb 2011

First patient treated in KUR-023 pilot clinical trial to assess safety and efficacy of product candidate

Kuros Biosurgery AG, a biotechnology company focused on the development of novel biomaterials and bioactive-biomaterial combination products for trauma, wound and spinal indications, announced today that it has treated the first patient in a pilot clinical trial investigating the safety and efficacy of KUR-023, its novel dural sealant product candidate.

28 Feb 2011

QIAGEN, Epigenomics enter option agreement to commercialize colorectal cancer blood test

Epigenomics AG, the cancer molecular diagnostics company, and QIAGEN today announced that the companies have entered into an option agreement allowing QIAGEN to develop and, should QIAGEN exercise the option, commercialize a colorectal cancer blood test based on Epigenomics' proprietary biomarker mSEPT9 and certain DNA methylation analysis technologies.

From QIAGEN Manchester Limited 28 Feb 2011

New research may shed light on how HIV virus reactivates from latency

New research enhances the current knowledge of how human immunodeficiency virus type-1, which causes AIDS, controls the cell cycle of cells that it infects. The new findings may shed light on how the virus reactivates after entering a dormant state, called latency.

28 Feb 2011

Final data from 4SC vidofludimus ENTRANCE Phase IIa trial against IBD presented at ECCO IBD Conference

4SC AG, a drug discovery and development company focused on autoimmune and cancer indications, announces the final data from the ENTRANCE Phase IIa trial in inflammatory bowel disease with vidofludimus, an oral inhibitor of interleukin-17 release and DHODH, including the secondary endpoints comprising the analysis of CDAI and CAI disease scores, change of prednisolone intake and threshold doses, safety, pharmacokinetics and biomarkers.

28 Feb 2011

Progressive groups offer support for maintaining Medicaid requirements

The nation's governors are will be in Washington this weekend for the National Governors Association winter meeting. Budget issues, especially related to Medicaid spending and other health costs, will be a hot topic.

28 Feb 2011

Pharming, Santarus receive FDA refusal to file letter for RHUCIN BLA

Specialty biopharmaceutical company Santarus, Inc.and biotech company Pharming Group NV today announced the receipt of a "refusal to file" letter from the U.S. Food and Drug Administration for the RHUCIN Biologics License Application submitted by Pharming.

28 Feb 2011

Medical News

U.S. food prices could rise up to 4%, USDA says

Despite FDA action, Deston still believes Auralgan as a safe and effective drug product

New horse stem cell discovery aids in preclinical model development for human degenerative diseases

Researchers discover new mechanism of beta cell destruction not previously known

First study to show link between AVPR1A gene variants with listening to music

Survey: 65% of patients in hospitals experience pain prevalence

Affymetrix introduces new GeneChip miRNA 2.0 Array

New study: Free radicals play a key role in heart physiology

Governors want flexibility from federal officials on health issues

Scientific Learning introduces new series of Virtual Brain Seminars for students

New national campaign to help reduce risk of pressure ulcers in hospital and post-acute care settings

Selcia completes drug discovery project with ExonHit Therapeutics using fragment screening technology

Preliminary top-line results from cariprazine 8-week Phase II trial against major depressive disorder

Temporary budget compromise would not defund health law

First patient treated in KUR-023 pilot clinical trial to assess safety and efficacy of product candidate

QIAGEN, Epigenomics enter option agreement to commercialize colorectal cancer blood test

New research may shed light on how HIV virus reactivates from latency

Final data from 4SC vidofludimus ENTRANCE Phase IIa trial against IBD presented at ECCO IBD Conference

Progressive groups offer support for maintaining Medicaid requirements

Pharming, Santarus receive FDA refusal to file letter for RHUCIN BLA

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Latest News